2014
DOI: 10.1136/gutjnl-2014-308101
|View full text |Cite
|
Sign up to set email alerts
|

Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics

Abstract: Perianal disease, stenosis and/or intra-abdominal fistulae at MRI independently predict an increased risk of resection surgery in patients with CD, whereas immunosuppressants and/or anti-TNF therapy reduce such risk. Under current therapeutic strategies, the presence of SELs is not a predictor of resection surgery in patients with CD.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
44
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(49 citation statements)
references
References 19 publications
(16 reference statements)
5
44
0
Order By: Relevance
“…These results were consistent with a previous report, which documented the positive correlation between the pre-operative bowel wall thickness and the risk of recurrence following conservative surgery for CD [64]. As expected, the detection of stricturing and/or penetrating complications at both US and MRI has been linked to a reduced surgery-free survival over a 12-24 month follow-up [63,65]. More surprisingly, the previously documented association between severe endoscopic lesions and the risk of surgical resection has no longer been confirmed in more recent reports [65], so as to suggest that abdominal imaging may be more useful than colonoscopy in the risk stratification of CD patients in the biologic era.…”
Section: Prediction Of the Need For Surgery And Response To Medical Tsupporting
confidence: 93%
“…These results were consistent with a previous report, which documented the positive correlation between the pre-operative bowel wall thickness and the risk of recurrence following conservative surgery for CD [64]. As expected, the detection of stricturing and/or penetrating complications at both US and MRI has been linked to a reduced surgery-free survival over a 12-24 month follow-up [63,65]. More surprisingly, the previously documented association between severe endoscopic lesions and the risk of surgical resection has no longer been confirmed in more recent reports [65], so as to suggest that abdominal imaging may be more useful than colonoscopy in the risk stratification of CD patients in the biologic era.…”
Section: Prediction Of the Need For Surgery And Response To Medical Tsupporting
confidence: 93%
“…Although ileocolonoscopy is generally considered the most accepted gold standard for assessing inflammatory lesions in CD patients, previous studies as well as the current study highlight important limitations [2,14,21]. Importantly, ten patients (23.25 %) had incomplete ileocolonoscopy due to severe stenosis or impossibility to intubate the terminal ileum but all of them were evaluated by MRE.…”
Section: Discussionmentioning
confidence: 77%
“…The accuracy of clinical assessment for the diagnosis of these complications is low [18,19], and endoscopy misses penetrating complications and, frequently, can only provide an incomplete assessment of stenosis. Both, penetrating and obstructive lesions represent independent predictors of risk for bowel resection surgery in patients with CD, even in subjects under biological therapy [20,21]. The inclusion of gadolinium sequences identified 11 patients with fistulas, whereas only 7 were detected by T2 sequences.…”
Section: Discussionmentioning
confidence: 99%
“…The utility of endoscopy for predicting intestinal surgery has not been fully established. Allez et al [28] reported that severe endoscopic lesions (SELs) have a more aggressive clinical course with an increased rate of surgery, while Jauregui-Amezaga et al [29] reported that the presence of SELs is not predictor of surgery in patients with CD. They emphasized the Number at risk (number of underwent surgery) (0) (5) (6) (6) (6) (8) (9) (9) (9) (9) 44 31 23 A B…”
Section: Mses-cd and The Risk Of Surgery For CDmentioning
confidence: 99%
“…In addition, infliximab therapy and disease duration were significantly associated with the event of surgery. JaureguiAmezaga et al [29] reported that immunosuppressants and anti-TNF therapy reduce the risk of the event of surgery, whereas prolonged disease duration significantly increases the risk of this event. Similar to these previous results, both infliximab and duration of disease were independent factors associated with surgery-free survival in this study.…”
Section: Figure 2 Kaplan-meier Analysis Of Surgery-free Survival Timementioning
confidence: 99%